StockMacro
Menu

ABVC BioPharma

ABVC on XNAS, ABVC BioPharma, Inc.

Measures activity, not value. Not investment advice.

Shares sold short (30 Oct 2026)

603K

+2.2% vs the report before

Short interest, % of shares outstanding

2.2%

27.0M shares outstanding (9 Nov 2026)

Days to cover

19.9

short interest / daily volume

Short sale volume share (20 Nov 2026)

22%

1-year median 25%

Sharp changes

6

short interest spike

Window
603K shares sold short on 30 Oct 2026, 2.2% of shares outstanding, 19.9 days to cover

FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.

See the numbers
30 Oct 2026: 603K shares sold short, 19.9 days to cover
15 Oct 2026: 590K shares sold short, 6.9 days to cover
30 Sep 2026: 490K shares sold short, 3.6 days to cover
15 Sep 2026: 505K shares sold short, 3.8 days to cover
31 Aug 2026: 525K shares sold short, 5.5 days to cover
14 Aug 2026: 429K shares sold short, 3.5 days to cover
31 Jul 2026: 442K shares sold short, 5.6 days to cover
15 Jul 2026: 465K shares sold short, 1.8 days to cover
30 Jun 2026: 367K shares sold short, 2.1 days to cover
15 Jun 2026: 391K shares sold short, 3.5 days to cover
29 May 2026: 259K shares sold short, 1.8 days to cover
15 May 2026: 273K shares sold short, 3.5 days to cover
30 Apr 2026: 258K shares sold short, 3.8 days to cover
15 Apr 2026: 295K shares sold short, 1.3 days to cover
31 Mar 2026: 265K shares sold short, 4.7 days to cover
13 Mar 2026: 248K shares sold short, 3.9 days to cover
27 Feb 2026: 247K shares sold short, 5.6 days to cover
13 Feb 2026: 248K shares sold short, 4.0 days to cover
30 Jan 2026: 251K shares sold short, 4.9 days to cover
15 Jan 2026: 343K shares sold short, 6.7 days to cover
31 Dec 2025: 347K shares sold short, 4.3 days to cover
15 Dec 2025: 366K shares sold short, 4.8 days to cover
28 Nov 2025: 377K shares sold short, 6.6 days to cover
14 Nov 2025: 386K shares sold short, 6.0 days to cover
31 Oct 2025: 391K shares sold short, 6.3 days to cover
15 Oct 2025: 428K shares sold short, 4.2 days to cover
30 Sep 2025: 636K shares sold short, 5.8 days to cover
15 Sep 2025: 651K shares sold short, 8.5 days to cover
29 Aug 2025: 701K shares sold short, 5.9 days to cover
15 Aug 2025: 706K shares sold short, 3.7 days to cover
31 Jul 2025: 618K shares sold short, 2.3 days to cover
15 Jul 2025: 568K shares sold short, 1.0 days to cover
30 Jun 2025: 645K shares sold short, 1.5 days to cover
13 Jun 2025: 507K shares sold short, 1.5 days to cover
30 May 2025: 451K shares sold short, 1.7 days to cover
15 May 2025: 444K shares sold short, 1.4 days to cover
30 Apr 2025: 317K shares sold short, 1.7 days to cover
15 Apr 2025: 255K shares sold short, 1.0 days to cover
31 Mar 2025: 288K shares sold short, 1.8 days to cover
14 Mar 2025: 321K shares sold short, 1.9 days to cover
28 Feb 2025: 416K shares sold short, 1.0 days to cover
14 Feb 2025: 258K shares sold short, 2.1 days to cover
31 Jan 2025: 220K shares sold short, 2.6 days to cover
15 Jan 2025: 293K shares sold short, 2.0 days to cover
31 Dec 2024: 360K shares sold short, 2.2 days to cover
13 Dec 2024: 628K shares sold short, 1.0 days to cover
29 Nov 2024: 253K shares sold short, 3.5 days to cover
15 Nov 2024: 334K shares sold short, 2.4 days to cover
31 Oct 2024: 186K shares sold short, 1.0 days to cover
15 Oct 2024: 138K shares sold short, 1.0 days to cover
30 Sep 2024: 132K shares sold short, 3.1 days to cover
13 Sep 2024: 111K shares sold short, 3.8 days to cover
30 Aug 2024: 138K shares sold short, 3.1 days to cover
15 Aug 2024: 127K shares sold short, 2.3 days to cover
31 Jul 2024: 180K shares sold short, 1.0 days to cover
15 Jul 2024: 163K shares sold short, 2.9 days to cover
28 Jun 2024: 228K shares sold short, 1.9 days to cover
14 Jun 2024: 370K shares sold short, 2.8 days to cover
31 May 2024: 435K shares sold short, 2.3 days to cover
15 May 2024: 588K shares sold short, 1.2 days to cover

What the numbers say

  • 603K shares sold short on 30 Oct 2026, 2.2% of shares outstanding, 19.9 days to cover; +2.2% on the report before, the most since Sep 2025 (published by FINRA on 10 Nov 2026).

Every measure from this source

Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.

Days to cover. 19.9 days in the report of 30 Oct 2026, 6.0 a year earlier.
Short interest, % of shares outstanding. 2.2% in the report of 30 Oct 2026, 1.6% a year earlier.
Daily short sale volume share on off-exchange venues. 22% of the off-exchange volume on 20 Nov 2026 was a short sale; its median of the last 12 months 25%. This is a daily flow, not short interest.

Sharp changes

6 in all loaded history, strongest first

ABVC BioPharma had 1.3M shares sold short in the 28 Mar 2024 report, 11× the same report last year.

Short interest spike, became public on 10 Apr 2024

Same report last year: 121K; its normal report is 108K.

See the evidence
This period
1.3M (the 28 Mar 2024 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
38K
How far from its usual level
+21.4
Same report last year
121K
History used
2,052 days
2023-03-31: 121K2023-04-14: 112K2023-04-28: 163K2023-05-15: 135K2023-05-31: 84K2023-06-15: 111K2023-06-30: 75K2023-07-14: 58K2023-07-31: 176K2023-08-15: 28K2023-08-31: 20K2023-09-15: 19K2023-09-29: 14K2023-10-13: 34K2023-10-31: 984K2023-11-15: 88K2023-11-30: 114K2023-12-15: 47K2023-12-29: 16K2024-01-12: 132K2024-01-31: 124K2024-02-15: 121K2024-02-29: 151K2024-03-15: 106K2024-03-28: 1.3M
the 28 Mar 2024 report24 earlier reportsnormal: 108K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

ABVC BioPharma had 984K shares sold short in the 31 Oct 2023 report, 60× the same report last year.

Short interest spike, became public on 10 Nov 2023

Same report last year: 16K; its normal report is 79K.

See the evidence
This period
984K (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
79K
Typical spread (median absolute deviation)
49K
How far from its usual level
+12.5
Same report last year
16K
History used
1,903 days
2022-10-31: 16K2022-11-15: 33K2022-11-30: 37K2022-12-15: 37K2022-12-30: 28K2023-01-13: 289K2023-01-31: 112K2023-02-15: 108K2023-02-28: 163K2023-03-15: 146K2023-03-31: 121K2023-04-14: 112K2023-04-28: 163K2023-05-15: 135K2023-05-31: 84K2023-06-15: 111K2023-06-30: 75K2023-07-14: 58K2023-07-31: 176K2023-08-15: 28K2023-08-31: 20K2023-09-15: 19K2023-09-29: 14K2023-10-13: 34K2023-10-31: 984K
the 31 Oct 2023 report24 earlier reportsnormal: 79K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

ABVC BioPharma had 638K shares sold short in the 30 Apr 2024 report, 3.9× the same report last year.

Short interest spike, became public on 10 May 2024

Same report last year: 163K; its normal report is 108K.

See the evidence
This period
638K (the 30 Apr 2024 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
52K
How far from its usual level
+6.8
Same report last year
163K
History used
2,085 days
2023-04-28: 163K2023-05-15: 135K2023-05-31: 84K2023-06-15: 111K2023-06-30: 75K2023-07-14: 58K2023-07-31: 176K2023-08-15: 28K2023-08-31: 20K2023-09-15: 19K2023-09-29: 14K2023-10-13: 34K2023-10-31: 984K2023-11-15: 88K2023-11-30: 114K2023-12-15: 47K2023-12-29: 16K2024-01-12: 132K2024-01-31: 124K2024-02-15: 121K2024-02-29: 151K2024-03-15: 106K2024-03-28: 1.3M2024-04-15: 533K2024-04-30: 638K
the 30 Apr 2024 report24 earlier reportsnormal: 108K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

ABVC BioPharma had 628K shares sold short in the 13 Dec 2024 report, 13× the same report last year.

Short interest spike, became public on 25 Dec 2024

Same report last year: 47K; its normal report is 157K.

See the evidence
This period
628K (the 13 Dec 2024 report)
Normal report (median of 24 earlier)
157K
Typical spread (median absolute deviation)
49K
How far from its usual level
+6.5
Same report last year
47K
History used
2,312 days
2023-12-15: 47K2023-12-29: 16K2024-01-12: 132K2024-01-31: 124K2024-02-15: 121K2024-02-29: 151K2024-03-15: 106K2024-03-28: 1.3M2024-04-15: 533K2024-04-30: 638K2024-05-15: 588K2024-05-31: 435K2024-06-14: 370K2024-06-28: 228K2024-07-15: 163K2024-07-31: 180K2024-08-15: 127K2024-08-30: 138K2024-09-13: 111K2024-09-30: 132K2024-10-15: 138K2024-10-31: 186K2024-11-15: 334K2024-11-29: 253K2024-12-13: 628K
the 13 Dec 2024 report24 earlier reportsnormal: 157K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

ABVC BioPharma had 533K shares sold short in the 15 Apr 2024 report, 4.8× the same report last year.

Short interest spike, became public on 25 Apr 2024

Same report last year: 112K; its normal report is 108K.

See the evidence
This period
533K (the 15 Apr 2024 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
47K
How far from its usual level
+6.1
Same report last year
112K
History used
2,070 days
2023-04-14: 112K2023-04-28: 163K2023-05-15: 135K2023-05-31: 84K2023-06-15: 111K2023-06-30: 75K2023-07-14: 58K2023-07-31: 176K2023-08-15: 28K2023-08-31: 20K2023-09-15: 19K2023-09-29: 14K2023-10-13: 34K2023-10-31: 984K2023-11-15: 88K2023-11-30: 114K2023-12-15: 47K2023-12-29: 16K2024-01-12: 132K2024-01-31: 124K2024-02-15: 121K2024-02-29: 151K2024-03-15: 106K2024-03-28: 1.3M2024-04-15: 533K
the 15 Apr 2024 report24 earlier reportsnormal: 108K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

ABVC BioPharma had 588K shares sold short in the 15 May 2024 report, 4.4× the same report last year.

Short interest spike, became public on 25 May 2024

Same report last year: 135K; its normal report is 108K.

See the evidence
This period
588K (the 15 May 2024 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
56K
How far from its usual level
+5.8
Same report last year
135K
History used
2,100 days
2023-05-15: 135K2023-05-31: 84K2023-06-15: 111K2023-06-30: 75K2023-07-14: 58K2023-07-31: 176K2023-08-15: 28K2023-08-31: 20K2023-09-15: 19K2023-09-29: 14K2023-10-13: 34K2023-10-31: 984K2023-11-15: 88K2023-11-30: 114K2023-12-15: 47K2023-12-29: 16K2024-01-12: 132K2024-01-31: 124K2024-02-15: 121K2024-02-29: 151K2024-03-15: 106K2024-03-28: 1.3M2024-04-15: 533K2024-04-30: 638K2024-05-15: 588K
the 15 May 2024 report24 earlier reportsnormal: 108K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.